Pakistan will consider using Dexa metha zone for corona patients: Dr Zafar Mirza

The drug can be used for severely affected patients, especially those on a ventilator, while it can be dangerous for less affected patients, Special Health Assistant

It has been decided to consider the use of Dexa Metha Zone for the critically ill patients of Corona in Pakistan . In a Twitter message, Special Health Assistant Dr Zafar Mirza said that they were considering using the drug on critically ill patients, but the committee would decide on its use together.

He added that the drug can be used for severely affected patients, especially those on ventilators, while it can be dangerous for less affected patients.

In a statement, he said that the drug has had positive results in the UK , while the World Health Organization has also called it a positive development in treatment .

Therefore, he said that now its use in Pakistan will be considered. The last day, British scientists Coruna disease treatment was discovered Affordable medicine, was quoted as dyksamythasun have recovered a third patient health ventilator medicine while it used the drug before 4 5,000 lives could have been saved.

According to British media, scientists in the UK have discovered a cheap medicine to treat corona. This medicine is part of the medicine used as a trial against corona virus in the world . In the light of these trials , the effect of these drugs in the treatment of corona is being seen. A very small amount of dexamethasone in these drugs has proven to be very useful in eradicating the corona virus.

Dexamethasone has been reported to reduce coronary heart disease mortality. One-third of the patients recovered from the drug on a ventilator. 4,000 to 5,000 lives could have been saved if the drug had been used first on critically ill patients. British scientists have called the treatment of corona a great success. The report further states that the cost of treatment for 10 days with this drug in the country is 5 pounds per patient. Dexamethasone costs 35 35 per patient to save the life of a critically ill patient. This drug can be very useful in developing and developing countries where there are a large number of corona patients.